Fig. 1From: Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patientsFlowchart of the study with PET/CT arm (part A) and PET/MRI arm (part B)Back to article page